The landscape of dementia prognosis has developed drastically with the appearance of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that will detect Alzheimer's pathology decades prior to signs or symptoms arise. Whilst these technological improvements stand for exceptional progress in comprehension neurod